Journals / Flora İnfeksiyon Hastalıkları ve Klinik Mikrobiyoloji Dergisi / 2018 / Cilt: 23 - Sayı: 2

Fever of Unknown Origin and Visceral Leishmaniasis: a Series of 20 Adult Patients

Nedeni Bilinmeyen Ateş ve Visseral Layşmanyaz: 20 Erişkin Hastadan Oluşan Olgu Serisi

Pages
92–94
Publication Date
2022-10-17
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Adultswith chronic systemic diseases are always at risk in endemic regions and VL should be considered in differential diagnosis, particularlyin cases of fever of unknown origin.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Visceral Leishmaniasis (VL) is a parasitic disease frequently seen in Mediterranean countries, including our country, which still constitutea major public health problem.
📊
Key Findings & Data:In this study, it was aimed to investigated retrospectively 20 cases diagnosed with visceral leishmaniasis(VL) among the cases referred from different clinics/centers for further examination to our department due to fever of unknown origin interms of demographic characteristics, underlying diseases, laboratory, clinical data and treatment results between 2007-2017.
💡
Conclusion & Impact:Adultswith chronic systemic diseases are always at risk in endemic regions and VL should be considered in differential diagnosis, particularlyin cases of fever of unknown origin.
🔬Design:Research Article
📍Scope:2007-2017 Verileri
⚙️Variables:Domain Parameters

Abstract

Visceral Leishmaniasis (VL) is a parasitic disease frequently seen in Mediterranean countries, including our country, which still constitutea major public health problem. In this study, it was aimed to investigated retrospectively 20 cases diagnosed with visceral leishmaniasis(VL) among the cases referred from different clinics/centers for further examination to our department due to fever of unknown origin interms of demographic characteristics, underlying diseases, laboratory, clinical data and treatment results between 2007-2017. Adultswith chronic systemic diseases are always at risk in endemic regions and VL should be considered in differential diagnosis, particularlyin cases of fever of unknown origin.

Özet

Giriş: Visseral layşmanyaz (VL), ülkemizin de içinde bulunduğu Akdeniz ülkelerinde sıklıkla görülen, halen önemli bir halk sağlığı sorunu olmaya devam eden paraziter bir hastalıktır. Bu çalışmada, 2007-2017 yılları arasında başka merkezlerden ileri tetkik amacıyla hastanemiz değişik kliniklerine yönlendirilen, uzun süreli ateş yüksekliği yakınması olan olgulardan yapılan incelemeler sonucu VL tanısı alan 20 olgu demografik özellikler, altta yatan hastalıklar, laboratuvar, klinik veriler ve tedavi sonuçları açısından retrospektif olarak değerlendirilmiştir. Kronik sistemik hastalıkları olan yetişkinlerde endemik bölgelerde her zaman VL riski altındadır ve ayırıcı tanılar arasında özellikle uzun süreli ateş yüksekliği olan olgularda VL akla gelmelidir.

🔖

Cite This Article

TURGAY, N., PULLUKÇU, H., TÖZ, S. Ö., AKYOL, D., SİPAHİ, O. R., TAŞBAKAN, M. I., YAMAZHAN, T. (2022). Fever of Unknown Origin and Visceral Leishmaniasis: a Series of 20 Adult Patients. Flora İnfeksiyon Hastalıkları ve Klinik Mikrobiyoloji Dergisi, Cilt: 23 - Sayı: 2, 92–94. https://ajindex.com/articles/517131

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (6)

  1. Aronson N, Herwaldt BL, Libman M, Pearson R, Lopez-Velez R, Weina P, et al. Guidelines: diagnosis and treatment of leishmaniasis: Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH). Am J Trop Med Hyg 2017;96(1):24-45. http://www.cdc.gov/parasites/Leishmaniasis/(Date of access: 18.10.2017)
  2. Den Boer M, Argaw D, Jannin J, Alvar J. Leishmaniasis impact and treatment access. Clin Microbiol Infect 2011;17:1471-7. WHO, 2010. Report of a Meeting of the WHO Expert Committee on the Control of Leishmaniases, Geneva 22-26 March, 2010. WHO Technical Report Series, pp. 949. http://www.who.int/leishmaniasis/resources/TURKEY (Date of access: 03.12.2017)
  3. Kopterides P, Mourtzoukou EG, Skopelitis E, Tsavaris N, Falagas ME. Aspects of the association between Leishmaniasis and malignant disorders. Trans R Soc Trop Med Hyg 2007;101:1181-9
  4. Kurşun E, Turunç T, Demircioglu YZ, Solmaz S, Arslan H. Evaluation of fourteen adult cases with visceral leishmaniasis. Mikrobiyol Bul 2013;47(3):500-6.
  5. Cruz I, Chicharro C, Nieto J, Bailo B, Canavate C, Figueras MC, et al. Comparison of new diagnostic tools for management of pediatric mediterranean visceral leishmaniasis. J Clin Microbiol 2006;44(7):2343-7.
  6. Erdem A, Taşbakan M, Pullukçu H, Töz SÖ, Sipahi OR, Yamazhan T, et al. Co-occurence of visceral leishmaniasis and lymphoma. Turk J Parasitol 2013;37(4):282-4.